SCHEMBL7818929

SCHEMBL7818929

COc1nc2c(-c3cc(Cl)c(Cl)cc3Cl)cccc2n1CC1(C2CC2)CC1

nearest known ligand 0.31

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 1/20 0.31
CD274 Q9NZQ7 1/20 0.31
NQO2 P16083 1/20 0.30
AVPR2 P30518 1/20 0.30
AVPR1A P37288 1/20 0.30
CRHR1 P34998 1/20 0.30
HTR3A P46098 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7819032 0.85 LMNA (0.35)
SCHEMBL7813709 0.76 CRHR1 (0.38) CRHR1
SCHEMBL7811659 0.73 LMNA (0.33)
SCHEMBL7818926 0.73 PDCD1LG2 (0.34) CD274NQO2CRHR1
SCHEMBL7810862 0.71 CRHR1 (0.40) CRHR1HTR3A
SCHEMBL7817047 0.70 NQO2 (0.37) NQO2CRHR1
SCHEMBL8009463 0.68
SCHEMBL7816969 0.64 CCNT1 (0.40)
SCHEMBL7813559 0.63 TLR8 (0.41)
SCHEMBL7817046 0.61 POLB (0.33) CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1091941-A1 NOVEL BENZIMIDAZOLES AS CORTICOTROPIN RELEASE FACTOR ANTAGONISTS Du Pont Pharmaceuticals Company (US) 2001-04-18 EP claimed
WO-2000001675-A1 NOVEL BENZIMIDAZOLES AS CORTICOTROPIN RELEASE FACTOR ANTAGONISTS DU PONT PHARMACEUTICALS COMPANY (US) 2000-01-13 WO claimed
EP-1091941-A1 NOVEL BENZIMIDAZOLES AS CORTICOTROPIN RELEASE FACTOR ANTAGONISTS Du Pont Pharmaceuticals Company (US) 2001-04-18 EP disclosed
US-6124463-A TREATMENT OF AFFECTIVE DISORDER, ANXIETY OR DEPRESSION DUPONT PHARMACEUTICALS (US) 2000-09-26 US disclosed
WO-2000001675-A1 NOVEL BENZIMIDAZOLES AS CORTICOTROPIN RELEASE FACTOR ANTAGONISTS DU PONT PHARMACEUTICALS COMPANY (US) 2000-01-13 WO disclosed